Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Health-related Quality of Life
83%
Pediatric Oncology
55%
Social Robots
41%
Childhood Cancer
36%
Dutch
35%
PedsQL
30%
Family Life
27%
Adolescents with Cancer
26%
Patient-Reported Outcomes Measurement Information System (PROMIS)
26%
Childhood Cancer Patients
25%
Cancer Treatment
23%
Pediatric Cancer
23%
Parent-proxy
23%
Children with Cancer
22%
Childhood Cancer Treatment
20%
First Year
20%
Normal Family
20%
Family Activities
20%
Family-centered
20%
Family Functioning
20%
Family Support
20%
Netherlands
20%
Proxy Measures
20%
Psychometric Properties
20%
Pediatric Quality of Life
20%
Toddlers
20%
National Cohort
20%
Methodological Resource
20%
Cancer Clinical Trials
20%
Sleep Hygiene
20%
Innovative Therapies
20%
Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
20%
Scoping Review
20%
Patient-reported Outcomes
20%
Combination Therapy
20%
Interaction Design
20%
Interactive Education
20%
Sensitive Settings
20%
Healthcare Providers
20%
Outpatient Clinic
20%
Life Data
20%
Behavior Profile
20%
Octopus
20%
Self-disclosure
20%
Getting Acquainted
20%
Young Adult Patients
20%
Platform Trials
20%
Oncology Outpatients
20%
Pediatrics-Adolescents
20%
During Treatment
19%
Nursing and Health Professions
Childhood Cancer
100%
Malignant Neoplasm
80%
Quality of Life
66%
Patient-Reported Outcome
41%
Pediatrics
41%
Pediatric Quality of Life Inventory
36%
Clinical Trial
24%
Robotics
24%
Cancer Therapy
22%
Family Functioning
20%
Pilot Study
20%
Information Systems
20%
Youth
20%
Reference Value
20%
Outcome Assessment
20%
Psychometry
20%
Health Care Personnel
20%
Scoping Review
20%
Education
20%
Outpatient Department
20%
Self Report
8%
Impaired Health
8%
Nausea
7%
Global Health
5%
Sleep Disorder
5%
Medicine and Dentistry
Childhood Cancer
86%
Malignant Neoplasm
63%
Quality of Life
49%
Adolescence
41%
Pediatrics
41%
Pediatric Quality of Life Inventory
27%
Cancer Therapy
22%
Sleep Hygiene
20%
Outpatient
20%
Family Functioning
20%
Family Life
20%
Education
20%
Health Care Personnel
20%
Rhabdomyosarcoma
20%
Soft Tissue Sarcoma
20%
Combination Therapy
20%
Experimental Therapy
16%
Active Treatment
10%
Diseases
8%
Nausea
7%
